The Personalized Medicine Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Personalized Medicine Market:
https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report
According to The Business Research Company’s Personalized Medicine Global Market Report 2024, The personalized medicine market size has grown rapidly in recent years. It will grow from $352.73 billion in 2023 to $390.65 billion in 2024 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to rise of companion diagnostics, patient-centric healthcare, drug development paradigm shift, healthcare cost containment, increasing prevalence of chronic diseases.
The personalized medicine market size is expected to see rapid growth in the next few years. It will grow to $590.51 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to continued genomic advancements, expansion of biomarker discovery, growing adoption of telemedicine, regulatory support and frameworks, collaboration and data sharing. Major trends in the forecast period include integration of artificial intelligence (AI), advancements in genomic sequencing, data integration and analytics, immunotherapy and targeted therapies, patient empowerment and informed decision-making, collaborations and partnerships.
The increasing prevalence of rare diseases is expected to propel the growth of the personalized medicine market going forward. The increasing prevalence of rare diseases refers to the growing number of people who are diagnosed with rare diseases such as Klinefelter Syndrome, Aarskog Syndrome, Abetalipoproteinemia, and others. Personalized medicine approaches help to provide more tailored treatment options for individuals with rare diseases which are on the rise. For instance, in March 2021, according to the Journal of the European Academy of Dermatology and Venereology, the population prevalence of rare diseases was estimated at 3.5%-5.9%. this is equal to 260-440 million individuals affected across the world at a time. Moreover, according to an article published by Global Genes, a US-based non-profit advocacy organization, Globally 400 million people are suffering from a rare disease. Therefore, the increase in the prevalence of rare diseases is driving the growth of the personalized medicine market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=10272&type=smp
The personalized medicine market covered in this report is segmented –
1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness
2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications
3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users
Major companies operating in the personalized medicine market are focusing on product launches, such as real-world data programs aimed at powering precision medicine solutions using real-world data for mental health. A real-world data program involves the systematic collection and analysis of information from everyday clinical practice and patient experiences to inform healthcare decisions and outcomes. For instance, in May 2022, Tempus, a US-based technology company that uses artificial intelligence to advance precision medicine, launched Tempus N+, a psychiatric real-world data program. The features include collaboration with academic medical institutions, an integrated operating system for mental health, secure data pipelines, access to real-world data, and an expansion of psychiatric care through EMR integration and pharmacogenomic testing. This launch significantly contributes to the personalized medicine market by advancing precision medicine solutions for mental health, utilizing real-world data, artificial intelligence, and academic collaborations to enhance treatment plans, improve patient outcomes, and empower data-driven decisions in mental health care.
The personalized medicine market report table of contents includes:
- Executive Summary
- Personalized Medicine Market Characteristics
- Personalized Medicine Market Trends And Strategies
- Personalized Medicine Market - Macro Economic Scenario
- Global Personalized Medicine Market Size and Growth
.
.
.
- Global Personalized Medicine Market Competitive Benchmarking
- Global Personalized Medicine Market Competitive Dashboard
- Key Mergers And Acquisitions In Personalized Medicine Market
- Personalized Medicine Market Future Outlook and Potential Analysis
- Appendix
Top Major Players :
- Bayer AG
- Novartis AG
- Thermo Fisher Scientific Inc.
- GlaxoSmithKline PLC
- AstraZeneca PLC
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases.
Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Additionally, personalized medicine offers opportunities to improve health care by lowering overall treatment costs.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=394Rise in the prevalence of various types of cancer, affordability of personalized medicine therapy in cancer drugs and various other disease indications, less side-effects of personalized medicine therapy, high adoption in developed markets, and development of innovative drugs are factors driving the global personalized medicine market.
However, high competition among existing market players, stringent government regulations regarding product approval, and lack of awareness among the rural population in developing economies are likely to hamper the market in the next few years.The global personalized medicine market is can be segmented based on product, application, distribution channel, and region.
The personalized medicine therapeutics segment is anticipated to hold the largest share of the global personalized medicine market during the forecast period, owing to rise in the prevalence of various types of cancer and chronic diseases.Request COVID Analysis on Personalized Medicine Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=394Based on application, the global personalized medicine market has been divided into cancer management, infectious diseases, central nervous system (CNS) disorders, blood transfusion safety, coagulation therapy, diabetes, autoimmune diseases, cardiovascular diseases, neurology, and psychiatry.
Based on distribution channel, the market can be categorized into hospitals pharmacies, retail pharmacies, dietary care centers, and others.
